293 related articles for article (PubMed ID: 18458097)
21. Altered ROS production, NF-κB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells.
Henríquez-Olguín C; Altamirano F; Valladares D; López JR; Allen PD; Jaimovich E
Biochim Biophys Acta; 2015 Jul; 1852(7):1410-9. PubMed ID: 25857619
[TBL] [Abstract][Full Text] [Related]
22. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.
Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG
PLoS One; 2010 May; 5(5):e10763. PubMed ID: 20505827
[TBL] [Abstract][Full Text] [Related]
23. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.
Hindi SM; Sato S; Choi Y; Kumar A
Hum Mol Genet; 2014 Mar; 23(6):1492-505. PubMed ID: 24163132
[TBL] [Abstract][Full Text] [Related]
25. AAV-based shRNA silencing of NF-κB ameliorates muscle pathologies in mdx mice.
Yang Q; Tang Y; Imbrogno K; Lu A; Proto JD; Chen A; Guo F; Fu FH; Huard J; Wang B
Gene Ther; 2012 Dec; 19(12):1196-204. PubMed ID: 22278411
[TBL] [Abstract][Full Text] [Related]
26. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
[TBL] [Abstract][Full Text] [Related]
27. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
28. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
30. Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function.
Yin X; Tang Y; Li J; Dzuricky AT; Pu C; Fu F; Wang B
Muscle Nerve; 2017 Oct; 56(4):759-767. PubMed ID: 27997693
[TBL] [Abstract][Full Text] [Related]
31. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
[TBL] [Abstract][Full Text] [Related]
32. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.
Cea LA; Puebla C; Cisterna BA; Escamilla R; Vargas AA; Frank M; Martínez-Montero P; Prior C; Molano J; Esteban-Rodríguez I; Pascual I; Gallano P; Lorenzo G; Pian H; Barrio LC; Willecke K; Sáez JC
Cell Mol Life Sci; 2016 Jul; 73(13):2583-99. PubMed ID: 26803842
[TBL] [Abstract][Full Text] [Related]
33. Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.
Altamirano F; Valladares D; Henríquez-Olguín C; Casas M; López JR; Allen PD; Jaimovich E
PLoS One; 2013; 8(12):e81222. PubMed ID: 24349043
[TBL] [Abstract][Full Text] [Related]
34. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Anderson JE; Vargas C
Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway.
St-Pierre SJ; Chakkalakal JV; Kolodziejczyk SM; Knudson JC; Jasmin BJ; Megeney LA
FASEB J; 2004 Dec; 18(15):1937-9. PubMed ID: 15456738
[TBL] [Abstract][Full Text] [Related]
36. Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells.
Moraes LH; Bollineli RC; Mizobuti DS; Silveira Ldos R; Marques MJ; Minatel E
Redox Rep; 2015 May; 20(3):109-15. PubMed ID: 25361473
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
[TBL] [Abstract][Full Text] [Related]
38. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
[TBL] [Abstract][Full Text] [Related]
39. Low-Level Laser Therapy (LLLT) in Dystrophin-Deficient Muscle Cells: Effects on Regeneration Capacity, Inflammation Response and Oxidative Stress.
Macedo AB; Moraes LH; Mizobuti DS; Fogaça AR; Moraes Fdos S; Hermes Tde A; Pertille A; Minatel E
PLoS One; 2015; 10(6):e0128567. PubMed ID: 26083527
[TBL] [Abstract][Full Text] [Related]
40. Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.
Reay DP; Niizawa GA; Watchko JF; Daood M; Reay JC; Raggi E; Clemens PR
Mol Med; 2012 May; 18(1):466-76. PubMed ID: 22231732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]